CII
GSK icon

Capital International Inc’s GSK GSK Stock Holding History

Capital International Inc’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,236
Closed -$216K – 285
2020
Q2 		$216K Buy
4,236
+1,300
+44% +$66.7K ﹤0.01% 262
2020
Q1 		$139K Buy
+2,936
New +$157K ﹤0.01% 246

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Capital International Inc's GSK Position: Q3 2020 in Review

Capital International Inc sold out of GSK (GSK) in Q3 2020, closing a stake of 4,236 shares — an estimated $216K sold.

Capital International Inc first reported a position in GSK in Q1 2020 and held it in 2 quarters. The position peaked at $216K in Q2 2020. 826 funds tracked by Wall St. Rank hold GSK as of Q3 2020.

  • Capital International Inc reported no remaining GSK position as of Q3 2020 after selling out during the quarter.
  • Capital International Inc sold 4,236 GSK shares in Q3 2020, an estimated $216K.
  • Capital International Inc first reported a position in GSK in Q1 2020 and held it in 2 quarters.
  • Capital International Inc's GSK position peaked at $216K in Q2 2020.
  • 826 funds tracked by Wall St. Rank held GSK as of Q3 2020.

Based on Capital International Inc's 13F filing for Q3 2020, filed 13 Nov 2020.